What is it about?
In this study we Show that CYP2W1 may be expressed in adrenocortical tissues and that CYP2W1 immunostaining may correlate with sensitivity to mitotane treatment . This may imply relevant clinical consequences for patients with adrenocortical cancer
Featured Image
Read the Original
This page is a summary of: CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma, PLoS ONE, August 2014, PLOS,
DOI: 10.1371/journal.pone.0105855.
You can read the full text:
Contributors
The following have contributed to this page
